Association of the single nucleotide polymorphism rs599839 in the vicinity of the sortilin 1 gene with LDL and triglyceride metabolism, coronary heart disease and myocardial infarction

The Ludwigshafen Risk and Cardiovascular Health Study



      The rs599839 polymorphism A/G in the vicinity of the sortilin 1 gene has been reported to be associated with low density lipoprotein cholesterol (LDL-C) and coronary artery disease (CAD). The objective of this study was to further characterize the protective effect of the minor allele by analyzing the association with a variety of quantitative traits.


      Association of rs599839 with plasma levels of different parameters of LDL and triglyceride (TRIG) metabolism as well as the risk of CAD was tested in the LURIC study cohort.


      Compared to AA homozygotes, the levels of LDL-C, low density lipoprotein triglycerides (LDL-TRIG) and apolipoprotein B were decreased in carriers of at least one G-allele. The G-allele was also associated with an increasing radius of the LDL particles. Regarding TRIG metabolism we observed a significant decrease in the level of triglycerides for homozygous carriers of the G-allele as well as decreased levels of free fatty acids (FFA), free glycerol and free cholesterol. With each G-allele the prevalence of CAD (multivariate OR 0.806; 95% CI: 0.6920.940, P = 0.006) decreased significantly whereas we observed only a marginal decrease for MI which did not reach significance.
      For GG homozygotes, the OR for CAD was 0.588 (95% CI: 0.3940.877; P = 0.009) and the OR for previous myocardial infarction (MI) was 0.693 (95% CI: 0.4900.980; P = 0.038). These associations were independent of cardiovascular risk factors.


      In the LURIC Study the G-allele of rs599839 is associated with LDL and TRIG metabolism and the risk of coronary artery disease and myocardial infarction.


      Apo (apolipoprotein), CAD (coronary artery disease), CI (confidence interval), FFA (free fatty acids), GWAS (genome-wide association studies), HDL-C (HDL cholesterol), LDL-C (LDL cholesterol), LDL-TRIG (LDL triglycerides), MAF (minor allele frequency), MI (myocardial infarction), OR (odds ratio), TRIG (triglycerides)


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661–78.

        • Samani N.J.
        • Erdmann J.
        • Hall A.S.
        • et al.
        Genomewide association analysis of coronary artery disease.
        N Engl J Med. 2007; 357: 443-453
        • Willer C.J.
        • Sanna S.
        • Jackson A.U.
        • et al.
        Newly identified loci that influence lipid concentrations and risk of coronary artery disease.
        Nat Genet. 2008; 40: 161-169
        • Kathiresan S.
        • Voight B.F.
        • Purcell S.
        • et al.
        Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants.
        Nat Genet. 2009;
        • Aulchenko Y.S.
        • Ripatti S.
        • Lindqvist I.
        • et al.
        Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts.
        Nat Genet. 2009; 41: 47-55
        • Muendlein A.
        • Geller-Rhomberg S.
        • Saely C.H.
        • et al.
        Significant impact of chromosomal locus 1p13.3 on serum LDL cholesterol and on angiographically characterized coronary atherosclerosis.
        Atherosclerosis. 2009;
        • Karvanen J.
        • Silander K.
        • Kee F.
        • et al.
        The impact of newly identified loci on coronary heart disease, stroke and total mortality in the MORGAM prospective cohorts.
        Genet Epidemiol. 2008;
        • Samani N.J.
        • Braund P.S.
        • Erdmann J.
        • et al.
        The novel genetic variant predisposing to coronary artery disease in the region of the PSRC1 and CELSR2 genes on chromosome 1 associates with serum cholesterol.
        J Mol Med. 2008; 86: 1233-1241
        • Kathiresan S.
        • Melander O.
        • Guiducci C.
        • et al.
        Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.
        Nat Genet. 2008; 40: 189-197
        • Sandhu M.S.
        • Waterworth D.M.
        • Debenham S.L.
        • et al.
        LDL-cholesterol concentrations: a genome-wide association study.
        Lancet. 2008; 371: 483-491
        • Wallace C.
        • Newhouse S.J.
        • Braund P.
        • et al.
        Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia.
        Am J Hum Genet. 2008; 82: 139-149
        • Schadt E.E.
        • Molony C.
        • Chudin E.
        • et al.
        Mapping the genetic architecture of gene expression in human liver.
        PLoS Biol. 2008; 6: e107
        • Kathiresan S.
        • Willer C.J.
        • Peloso G.M.
        • et al.
        Common variants at 30 loci contribute to polygenic dyslipidemia.
        Nat Genet. 2009; 41: 56-65
        • Sabatti C.
        • Service S.K.
        • Hartikainen A.L.
        • et al.
        Genome-wide association analysis of metabolic traits in a birth cohort from a founder population.
        Nat Genet. 2009; 41: 35-46
        • Winkelmann B.R.
        • Marz W.
        • Boehm B.O.
        • et al.
        Rationale and design of the LURIC study—a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.
        Pharmacogenomics. 2001; 2: S1-S73
        • Austen W.G.
        • Edwards J.E.
        • Frye R.L.
        • et al.
        A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association.
        Circulation. 1975; 51: 5-40
      2. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2006;29(Suppl. 1):S43–8.

        • Baumstark M.W.
        • Kreutz W.
        • Berg A.
        • Frey I.
        • Keul J.
        Structure of human low-density lipoprotein subfractions, determined by X-ray small-angle scattering.
        Biochim Biophys Acta. 1990; 1037: 48-57
        • Nielsen M.S.
        • Jacobsen C.
        • Olivecrona G.
        • Gliemann J.
        • Petersen C.M.
        Sortilin/neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase.
        J Biol Chem. 1999; 274: 8832-8836
        • Nilsson S.K.
        • Christensen S.
        • Raarup M.K.
        • Ryan R.O.
        • Nielsen M.S.
        • Olivecrona G.
        Endocytosis of apolipoprotein A-V by members of the low density lipoprotein receptor and the VPS10p domain receptor families.
        J Biol Chem. 2008; 283: 25920-25927
        • Lamarche B.
        • Tchernof A.
        • Moorjani S.
        • et al.
        Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study.
        Circulation. 1997; 95: 69-75
        • Slyper A.H.
        Low-density lipoprotein density and atherosclerosis. Unraveling the connection.
        JAMA. 1994; 272: 305-308
        • Rapp R.J.
        Hypertriglyceridemia: a review beyond low-density lipoprotein.
        Cardiol Rev. 2002; 10: 163-172
        • Sprecher D.L.
        Triglycerides as a risk factor for coronary artery disease.
        Am J Cardiol. 1998; 82 ([discussion 85U–86U]): 49U-56U
        • McPherson R.
        • Pertsemlidis A.
        • Kavaslar N.
        • et al.
        A common allele on chromosome 9 associated with coronary heart disease.
        Science. 2007; 316: 1488-1491
        • Schunkert H.
        • Gotz A.
        • Braund P.
        • et al.
        Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease.
        Circulation. 2008; 117: 1675-1684
        • Jarinova O.
        • Stewart A.F.
        • Roberts R.
        • et al.
        Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus.
        Arterioscler Thromb Vasc Biol. 2009;